CATALYST PHARMACEUTICALS INC. - COMMON STOCK

Catalyst Pharmaceuticals Notified of Abbreviated New Drug Application Filing for FIRDAPSE®

23 يناير 2023 08:03:00 بحسب Nasdaq GlobeNewswire

Catalyst Pharmaceuticals to Acquire U.S. Commercial Rights to FYCOMPA® (Perampanel) CIII From Eisai Co., Ltd

19 ديسمبر 2022 16:10:00 بحسب Nasdaq GlobeNewswire

Catalyst Pharmaceuticals Reports Record Third Quarter 2022 Financial Results and Provides a Corporate Update

09 نوفمبر 2022 16:11:31 بحسب Nasdaq GlobeNewswire

Catalyst Pharmaceuticals Named BioFlorida 2022 Company of the Year

07 نوفمبر 2022 08:03:37 بحسب Nasdaq GlobeNewswire

Catalyst Pharmaceuticals to Report Third Quarter 2022 Financial Results on November 9, 2022

25 أكتوبر 2022 08:03:00 بحسب Nasdaq GlobeNewswire

Catalyst Pharmaceuticals Announces FDA Approval of Supplemental New Drug Application for FIRDAPSE® Expanding Patient Population to Include Pediatric Patients

29 سبتمبر 2022 11:18:17 بحسب Nasdaq GlobeNewswire

Catalyst Pharmaceuticals to Participate in the H.C. Wainwright 24th Annual Global Investment Conference

09 سبتمبر 2022 08:03:00 بحسب Nasdaq GlobeNewswire

Catalyst Pharmaceuticals To Participate in Citi's 17th Annual BioPharma Conference

24 أغسطس 2022 08:03:00 بحسب Nasdaq GlobeNewswire

Catalyst Pharmaceuticals Delivers Strong Second Quarter 2022 Financial Results with Record FIRDAPSE® Revenues and Provides Corporate Update

09 أغسطس 2022 16:26:30 بحسب Nasdaq GlobeNewswire

Catalyst Pharmaceuticals to Report Second Quarter 2022 Financial Results on August 9, 2022

26 يوليو 2022 08:03:00 بحسب Nasdaq GlobeNewswire

Catalyst Pharmaceuticals Announces Settlement of U.S. Patent Litigation and Resolution of Litigation Challenging Ruzurgi® Approval with Jacobus Pharmaceutical

12 يوليو 2022 06:00:00 بحسب Nasdaq GlobeNewswire

Catalyst Pharmaceuticals to Participate in Two Upcoming Investor Conferences

17 مايو 2022 08:03:00 بحسب Nasdaq GlobeNewswire

Catalyst Pharmaceuticals Reports Record First Quarter 2022 Financial Results And Provides Corporate Update

10 مايو 2022 16:11:56 بحسب Nasdaq GlobeNewswire

Catalyst Pharmaceuticals to Report First Quarter 2022 Financial Results on May 10, 2022

25 أبريل 2022 08:03:00 بحسب Nasdaq GlobeNewswire

Catalyst Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update

16 مارس 2022 16:20:58 بحسب Nasdaq GlobeNewswire

Catalyst Pharmaceuticals and KYE Pharmaceuticals Announce a Second Favorable Canadian Federal Court Ruling Setting Aside Approval of Ruzurgi®

11 مارس 2022 08:03:00 بحسب Nasdaq GlobeNewswire

Catalyst Pharmaceuticals Named Among Forbes 2022 America's Best Small Companies

08 مارس 2022 08:03:00 بحسب Nasdaq GlobeNewswire

Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2021 Financial Results on March 16, 2022

03 مارس 2022 09:20:00 بحسب Nasdaq GlobeNewswire

Catalyst Pharmaceuticals Further Strengthens FIRDAPSE® U.S. Patent Portfolio

02 مارس 2022 08:03:00 بحسب Nasdaq GlobeNewswire

Catalyst Pharmaceuticals Teams Up with Patients and Advocacy Groups to Ring Nasdaq Opening Bell on Rare Disease Day 2022

24 فبراير 2022 08:03:00 بحسب Nasdaq GlobeNewswire